KalVista Pharmaceuticals (KALV) Insider Trading & Ownership

$12.60

+0.02 (+0.16%)

(As of 09:47 AM ET)

Current Insider Ownership Percentage: 12.30%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $5.81 M
Number Of Insiders Selling (Last 12 Months): 5
Amount Of Insider Selling (Last 12 Months): $2.84 M

Get KALV Insider Trade Alerts

Want to know when executives and insiders are buying or selling KalVista Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KALV Insider Buying and Selling by Quarter

Ad Angel Publishing

What Is the $7,882 Stimulus Payment 2024?

Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.

Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here.

KalVista Pharmaceuticals Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/19/2024	Benjamin L Palleiko	CEO	Sell	14,215	$12.01	$170,722.15
8/19/2024	Christopher Yea	Insider	Sell	7,102	$12.01	$85,295.02
6/7/2024	Benjamin L Palleiko	CEO	Sell	7,465	$11.53	$86,071.45
5/20/2024	Benjamin L Palleiko	CEO	Sell	21,959	$11.76	$258,237.84
5/20/2024	Edward P Feener	Insider	Sell	8,088	$11.76	$95,114.88
2/20/2024	Benjamin L Palleiko	CFO	Sell	22,802	$14.11	$321,736.22
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
2/20/2024	Edward P Feener	Insider	Sell	28,288	$14.07	$398,012.16
2/20/2024	Thomas Andrew Crockett	CEO	Sell	24,888	$14.11	$351,169.68
2/8/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	29,747	$14.70	$437,280.90
2/6/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	4,474	$14.74	$65,946.76
1/29/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	80,600	$14.22	$1,146,132.00
1/26/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	4,174	$12.98	$54,178.52
1/24/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	20,686	$12.44	$257,333.84
1/22/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	67,546	$12.55	$847,702.30
1/18/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	39,680	$12.51	$496,396.80
1/16/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	19,599	$12.73	$249,495.27
1/11/2024	Edward P Feener	Insider	Sell	22,679	$13.03	$295,507.37
1/10/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	47,700	$12.67	$604,359.00
1/8/2024	Edward P Feener	Insider	Sell	17,221	$13.01	$224,045.21
1/8/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	69,184	$12.44	$860,648.96
1/3/2024	Venrock Healthcare Capital Par	Major Shareholder	Buy	17,605	$12.20	$214,781.00
12/29/2023	Venrock Healthcare Capital Par	Major Shareholder	Buy	6,013	$12.49	$75,102.37
12/27/2023	Thomas Andrew Crockett	CEO	Sell	30,000	$12.02	$360,600.00
12/27/2023	Venrock Healthcare Capital Par	Major Shareholder	Buy	41,514	$11.97	$496,922.58
9/11/2023	Albert Cha	Director	Sell	18,000	$10.50	$189,000.00

(Data available from 1/1/2013 forward)

KALV Insider Trading Activity - Frequently Asked Questions

Who is on KalVista Pharmaceuticals's Insider Roster?: The list of insiders at KalVista Pharmaceuticals includes Albert Cha, Benjamin L Palleiko, Christopher Yea, Edward P Feener, Paul K Audhya, Thomas Andrew Crockett, and Venrock Healthcare Capital Par. Learn more on insiders at KALV.
What percentage of KalVista Pharmaceuticals stock is owned by insiders?: 12.30% of KalVista Pharmaceuticals stock is owned by insiders. Learn more on KALV's insider holdings.
Which KalVista Pharmaceuticals insiders have been buying company stock?: The following insider purchased KALV shares in the last 24 months: Venrock Healthcare Capital Par ($5,806,280.30).

How much insider buying is happening at KalVista Pharmaceuticals?: Insiders have purchased a total of 448,522 KALV shares in the last 24 months for a total of $5,806,280.30 bought.
Which KalVista Pharmaceuticals insiders have been selling company stock?: The following insiders have sold KALV shares in the last 24 months: Albert Cha ($189,000.00), Benjamin L Palleiko ($1,059,787.07), Christopher Yea ($117,895.74), Edward P Feener ($1,012,679.62), Paul K Audhya ($112,190.52), and Thomas Andrew Crockett ($989,479.34).
How much insider selling is happening at KalVista Pharmaceuticals?: Insiders have sold a total of 289,650 KalVista Pharmaceuticals shares in the last 24 months for a total of $3,481,032.29 sold.